Systemic bioavailability of estriol following single and repeated vaginal administration of 0.03 mg estriol containing pessaries.

Single vaginal application of pessaries containing 0.03 mg estriol resulted in a very low systemic bioavailability, which decreased even more after multiple dosing confirming a favourable safety profile of low dose pessaries administered daily over 21 days.